Philip Day's Biography

Philip Day, Reader, The University of Manchester

Philip Day is Reader in Quantitative Analytical Genomics, Manchester University, Director of Quantitative Molecular Medicine and Principal Investigator at the Manchester Interdisciplinary Biocentre. He has developed innovative tools for precise and accurate measurement of transcripts in heterogeneous tissues and for application in cancer studies.  Philip heads a group investigating the systems pathology of neuroblastoma and leukemia, and molecular biomarkers relating to prognostics. Current studies focus on assay miniaturization for single cell analyses to enable understanding of drug response activities across cell populations and cell-cell interactions. Through close collaborative studies with groups in analytical instrumentation, miniaturization, data analysis, text mining and systems biology, he is engaging biomarker integration for enabling personalized healthcare. He has over 90 peer reviewed papers and is an examiner for various research councils and journals, and RSC Editorial Board member.